<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00669760</url>
  </required_header>
  <id_info>
    <org_study_id>Muko e.V. S05/07</org_study_id>
    <nct_id>NCT00669760</nct_id>
  </id_info>
  <brief_title>Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients</brief_title>
  <acronym>StaphCI</acronym>
  <official_title>Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients, a Non-interventional, Prospective, Longitudinal Multicenter Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mukoviszidose eV Bonn Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Muenster</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Staphylococcus aureus is not only one of the first pathogens infecting the airways of cystic
      fibrosis (CF) patients, but also a highly prevalent microorganism (&gt;60% of all CF patients;
      European and American CF registries; (4,25), which often persists for several years in the
      respiratory tract of CF patients.

      The purpose of this study is to dissect infection by S. aureus from colonization. Therefore,
      the following non-interventional prospective, longitudinal multicenter study will be
      conducted to develop the following hypothesis:

      CF patients with high bacterial loads are more likely to be infected by S. aureus than
      patients with low bacterial loads.

      Primary endpoint: bacterial load of sputum cultures

      Secondary endpoints:

        -  nasal carriage

        -  molecular analysis of S. aureus (Monoclonal/polyclonal)

        -  serum: S. aureus-specific antibodies, S100A12, IL-8, TNF-alpha

        -  sputum: S100A12, IL-8, myeloperoxidase

        -  S. aureus therapy regimens

        -  lung function tests: FEV1, deltaFVC , deltaMEF25

        -  BMI development

      Inclusion criteria: S. aureus cultures for more than 6 months within the last year, children
      (&gt;6 years) and patients, who are able to perform lung function tests Exclusion criteria: P.
      aeruginosa and/or B. cepacia cultures from the specimens for more than 6 months within the
      last year before recruitment or during the study period In addition to microbiological
      investigations and clinical laboratory tests, the actual clinical situation will be evaluated
      and reported during the study period. The results of this observational study will be used to
      carefully plan a clinical interventional study. Furthermore, with the results it might be
      possible to characterize a subpopulation of patients, which is at greater risk for S. aureus
      infections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Protocol synopsis Title: Dissection of Staphylococcus aureus infection from colonization in
      cystic fibrosis patients. A non-interventional prospective, 2-year longitudinal multicenter
      study

      Study objectives: The aim of the study is to dissect S. aureus infection from colonization of
      the pathogen in airway secretions of CF patients during a 2 year period by means of a
      non-interventional, prospective, longitudinal multicenter study.

      The following hypothesis will be developed:

      CF patients with high bacterial loads are more likely to be infected by S. aureus than
      patients with low bacterial loads.

      Definition of infection:

        -  change in volume, colour or consistency of sputum (exacerbation)

        -  increased cough

        -  malaise, fatigue or lethargy

        -  body temperature more than 38°C

        -  new or increased hemoptysis

        -  anorexia or weight loss

        -  sinus pain or tenderness

        -  change in sinus discharge

        -  change in chest sounds

        -  ten percent decrease in pulmonary function from a previous recorded value (FEV1, MEF25)

        -  radiographic changes indicative of pulmonary infection

      Primary endpoint: bacterial load of sputum cultures [high (&gt;/= 106CFU/ml); low (&lt;106CFU/ml)]

      Secondary endpoints are:

        -  assessment of nasal S. aureus carriage

        -  serum samples: antibody titres against S. aureus specific antigens; S100A12,
           IL-8,TNF-alpha, CRP

        -  molecular analysis of S. aureus colonization/infection (monoclonal or heteroclonal)

        -  sputa analysis: activity of S100A12, IL-8 and myeloperoxidase

        -  antibiotic treatment regimens against S. aureus

        -  body mass index

        -  lung function tests: FEV1, deltaFVC, deltaMEF25

      Extensive microbiological investigations will be performed when the patients are seen at
      their regular visits in the outpatient clinics or if exacerbations occur. During the study
      period of 2 years, at least 8 visits to the outpatient clinic should be recorded. The
      following clinical parameters will be documented:

        -  lung function

        -  body mass index (weight/height)

        -  antibiotic treatment Diagnosis: CF and positive S. aureus cultures for more than 6
           months within the last year Localisation of the study: multicenter study in Germany
           Number of centers: Seven centres agreed already to participate in the study. More
           centers have been and will be contacted.

      Design: non-interventional prospective, longitudinal multicenter study Planned number of
      patients/volunteers: 228 Inclusion criteria: positive S. aureus cultures for more than 6
      months within the last year; children (&gt;6 years) and patients with CF, who are able to
      perform lung function tests Exclusion criteria: Pseudomonas aeruginosa and/or Burkholderia
      cepacia colonization or infection for more than 6 months within the last year before
      recruitment; patients who have not been colonized with these pathogens before but acquire
      them within the study period and are colonized/infected for more than 6 months during the
      observation period
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>bacterial load of sputum cultures [high (&gt;/= 1000000CFU/ml); low (&lt;1000000CFU/ml)]</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>antibody titres against S. aureus specific antigens; S100A12, IL-8, TNF-alpha, CRP</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">195</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Observation</arm_group_label>
    <description>CF-patients with persistent culture of Staphylococcus aureus in their respiratory specimens</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>non-interventional study</intervention_name>
    <description>does not apply</description>
    <arm_group_label>Observation</arm_group_label>
    <other_name>does not apply</other_name>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Sera
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        CF-patients with persistent S. aureus culture in their airway specimens
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  positive S. aureus cultures for more than 6 months within the last year; children (&gt;6
             years) and patients with CF, who are able to perform lung function tests

        Exclusion Criteria:

          -  Pseudomonas aeruginosa and/or Burkholderia cepacia colonization or infection for more
             than 6 months within the last year before recruitment; patients who have not been
             colonized with these pathogens before but acquire them within the study period and are
             colonized/infected for more than 6 months during the observation period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara C Kahl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. Med. Microbiology, University Clinics Muenster, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medizinische Universität Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite Berlin Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12200</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic for Children and Adolescents Ruhr University Bochum St Josef Hospital</name>
      <address>
        <city>Bochum</city>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heinrich-Heine University Duesseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Clinics Essen</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ruhrlandklinik Essen-Heidhausen</name>
      <address>
        <city>Essen</city>
        <zip>45239</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Halle</name>
      <address>
        <city>Halle</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dres Heuer-Runge-Sextro</name>
      <address>
        <city>Hamburg</city>
        <zip>22763</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical School Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Clinics Jena</name>
      <address>
        <city>Jena</city>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Park Schoenfeld</name>
      <address>
        <city>Kassel</city>
        <zip>34121</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Clinics Muenster</name>
      <address>
        <city>Muenster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clemenshospital</name>
      <address>
        <city>Muenster</city>
        <zip>48153</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Osnabrueck</name>
      <address>
        <city>Osnabrueck</city>
        <zip>49082</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Clinics Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://mikrobiologie.klinikum.uni-muenster.de</url>
  </link>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2008</study_first_submitted>
  <study_first_submitted_qc>April 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2008</study_first_posted>
  <last_update_submitted>January 6, 2015</last_update_submitted>
  <last_update_submitted_qc>January 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Muenster</investigator_affiliation>
    <investigator_full_name>Barbara Kahl</investigator_full_name>
    <investigator_title>Prof. Dr. Barbara Kahl</investigator_title>
  </responsible_party>
  <keyword>cystic fibrosis</keyword>
  <keyword>Staphylococcus aureus</keyword>
  <keyword>persistent colonization-infection</keyword>
  <keyword>clinical status</keyword>
  <keyword>lung function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Staphylococcal Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

